Venus Remedies Ltd.
VENUSREM Share PricePharmaceuticals & Drugs
₹764.15
-6.9 (-0.9%)
As on December 4, 2025
Exchange Scrips: BSE526953NSEVENUSREMISININE411B01019
Market Cap ₹ 1,029 Cr
P/E Ratio 22.54
Dividend Yield N/A
Performance
Market performance
Open779
High779
Volumes62,573
Prev764.15
Low732.5
As on2025-12-04
Historical performance
1 Year High799.8
3 Year High799.8
5 Year High799.8
1 Year Low270.25
3 Year Low145.8
5 Year Low116.05
Fundamentals
Company Valuation
Market Cap (₹Cr)
1,029
Face Value (₹)
10
P/E Ratio
22.54
Dividend Yield
N/A
Investment Returns
1 Year
134.3%
3 Years
283.8%
5 Years
469.6%
10 Years
475.6%
Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 743.34 | Bullish |
| 10-DMA | 722.87 | Bullish |
| 20-DMA | 639.59 | Bullish |
| 50-DMA | 525.25 | Bullish |
| 100-DMA | 505.74 | Bullish |
| 200-DMA | 429.95 | Bullish |
Shareholding Pattern
| Field | Sep-2025 | Jun-2025 | Mar-2025 | Dec-2024 | Sep-2024 |
|---|---|---|---|---|---|
| Promoters | 5 | 5 | 5 | 5 | 5 |
| Foreign Investors | --- | --- | --- | --- | --- |
| Domestic Investors | 5 | 5 | 5 | 5 | 5 |
| Public Investors | 17720 | 19302 | 19977 | 19766 | 19552 |
| Government | --- | --- | --- | --- | --- |
Financials
Below figures are in Rs. Crores
Balance Sheet
Below figures are in Rs. Crores
Cash Flow
Below figures are in Rs. Crores
0%
Negative
Neutral
Positive
- The stock has a PE ratio of 22.54.
- 3Y Stock Price CAGR of the stock is 57.6.
- The stock has a beta of 1.0.
- In the last financial year, the company had an EBITDA of ₹845 Million.
- The company generated revenue of ₹6479 Million in the previous financial year.
Venus Remedies Ltd.
764.15-6.9 (-0.9%)
₹
Investment Amount: ₹ 1000000
Current Value: ₹ 2364691.3
No. of Shares: 3095 (Approx)
Performance:136.5%
P/L: ₹1364691.3
Top Gainers
Peer Comparison
Get Your Portfolio Reviewed
